Clinical Trial Update: TCF7L2 Polymorphisms Influence on Glycemic Control in ICU Patients With Organ Failure

View source ↗

Summary

A completed clinical trial evaluating whether TCF7L2 genetic polymorphisms influence glycemic control in ICU patients with organ failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Multiple Organ Dysfunction Syndrome

Snippet

Sponsor: University Hospital, Lille | Conditions: Genetic Predisposition to Disease, Hyperglycemia | Status: COMPLETED